Sorafenib: atypical cutaneous side effects

Eur J Dermatol. 2007 Nov-Dec;17(6):549-50. doi: 10.1684/ejd.2007.0283. Epub 2007 Oct 19.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents / adverse effects*
  • Benzenesulfonates / adverse effects*
  • Carcinoma, Renal Cell / drug therapy
  • Drug Eruptions / etiology*
  • Drug Eruptions / pathology
  • Humans
  • MAP Kinase Kinase Kinases / antagonists & inhibitors
  • Male
  • Neoplasm Metastasis / drug therapy
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Protein Kinase Inhibitors / adverse effects*
  • Pyridines / adverse effects*
  • Skin Diseases, Vesiculobullous / chemically induced*
  • Skin Diseases, Vesiculobullous / pathology
  • Sorafenib

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Phenylurea Compounds
  • Protein Kinase Inhibitors
  • Pyridines
  • Niacinamide
  • Sorafenib
  • MAP Kinase Kinase Kinases